MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

blood pressure

  • Home
  • blood pressure
甲吡酮治疗轻度自主性皮质醇分泌:心血管获益与机制启示
Posted inCardiology Clinical Updates Diabetes & Endocrinology

Metyrapone Treatment in Mild Autonomous Cortisol Secretion: Cardiovascular Benefits and Mechanistic Insights

Posted by By MedXY 11/02/2026
A 12-week metyrapone regimen lowers blood pressure and reduces epicardial fat in patients with mild autonomous cortisol secretion, suggesting cardiovascular improvements without altering cardiac morphology or function.
Read More
A Recipe for Better Diabetes Management: Embracing the DASH4D Dietary Pattern
Posted inCardiology Diabetes & Endocrinology news

A Recipe for Better Diabetes Management: Embracing the DASH4D Dietary Pattern

Posted by By MedXY 10/27/2026
The DASH4D diet, a diabetes-adapted version of the DASH eating plan, significantly improves blood pressure and blood sugar control in type 2 diabetes with hypertension, offering a strong evidence-based dietary recommendation for personalized nutrition therapy.
Read More
24小时血压波动对原发性开角型青光眼视网膜神经纤维层进展的影响
Posted innews Ophthalmology

Impact of 24-Hour Blood Pressure Variability on Retinal Nerve Fiber Layer Progression in Primary Open-Angle Glaucoma

Posted by By MedXY 10/23/2026
Lower systemic blood pressure, especially minimum values measured over 24 hours, is associated with accelerated retinal nerve fiber layer loss in primary open-angle glaucoma, highlighting the prognostic value of ambulatory BP monitoring.
Read More
Remote Blood Pressure Monitoring Versus Office Visits in High-Risk Preeclampsia: A Multicenter RCT
Posted innews OB/GYN & Women's Health

Remote Blood Pressure Monitoring Versus Office Visits in High-Risk Preeclampsia: A Multicenter RCT

Posted by By MedXY 10/07/2026
A multicenter RCT demonstrates remote blood pressure monitoring reduces antenatal visits and hospital admissions without compromising maternal or fetal outcomes in women at high risk of preeclampsia.
Read More
Whole-grain Consumption and Cardiometabolic Risk: A Meta-analysis of Randomized Trials
Posted inCardiology Diabetes & Endocrinology news

Whole-grain Consumption and Cardiometabolic Risk: A Meta-analysis of Randomized Trials

Posted by By MedXY 09/21/2026
This meta-analysis of 87 randomized trials finds that increasing whole-grain intake is associated with improved cardiometabolic risk factors including reduced body weight, cholesterol, and blood pressure, particularly at daily intakes of 60-100 grams.
Read More
Impact of a Community- and Family-Based Intervention on Blood Pressure Reduction in Rural China: Insights from a Cluster-Randomized Trial
Posted inCardiology news Public Health

Impact of a Community- and Family-Based Intervention on Blood Pressure Reduction in Rural China: Insights from a Cluster-Randomized Trial

Posted by By MedXY 08/28/2026
This cluster-randomized trial in rural China demonstrates that a coordinated community- and family-based intervention effectively lowers systolic blood pressure at the population level, highlighting the importance of sustained community engagement for hypertension control.
Read More
Comorbid Insomnia Amplifies Blood Pressure Reduction with CPAP Therapy in Obstructive Sleep Apnea Patients
Posted inCardiology news Respiratory

Comorbid Insomnia Amplifies Blood Pressure Reduction with CPAP Therapy in Obstructive Sleep Apnea Patients

Posted by By MedXY 08/04/2026
In patients with OSA and elevated blood pressure, comorbid insomnia is linked to a significantly greater blood pressure reduction following short-term CPAP therapy, highlighting the clinical importance of addressing both sleep disorders.
Read More
Effects of Exercise and Intensive Vascular Risk Reduction on Cognitive Function in Older Adults: A Randomized Clinical Trial
Posted inCardiology Neurology news

Effects of Exercise and Intensive Vascular Risk Reduction on Cognitive Function in Older Adults: A Randomized Clinical Trial

Posted by By MedXY 05/16/2026
A 24-month randomized trial found that exercise, intensive blood pressure and cholesterol control, or both together did not significantly improve cognitive function in older adults at increased risk for dementia.
Read More
Bradykinin’s Modest Role in Sacubitril/Valsartan’s Blood Pressure Effects Revealed
Posted inCardiology news

Bradykinin’s Modest Role in Sacubitril/Valsartan’s Blood Pressure Effects Revealed

Posted by By MedXY 04/24/2026
A study finds bradykinin modestly contributes to blood pressure reduction with sacubitril/valsartan in chronic heart failure, highlighting ANP's role in initial effects and bradykinin's influence during chronic therapy.
Read More
Shear Stress-Induced Endothelial HEG1 Signalling: A Novel Pathway Linking Blood Flow to Blood Pressure Regulation
Posted inCardiology news

Shear Stress-Induced Endothelial HEG1 Signalling: A Novel Pathway Linking Blood Flow to Blood Pressure Regulation

Posted by By MedXY 04/17/2026
Researchers identify HEG1 as a critical flow-sensitive endothelial protein that regulates blood pressure through CUL3-mediated degradation of PHACTR1, linking reduced shear stress in hypertension to impaired NO production and vascular dysfunction.
Read More
Even ‘Elevated’ Blood Pressure Raises Dementia Risk: Insights from 2.8 Million Adults Over 8 Years
Posted inCardiology Neurology news

Even ‘Elevated’ Blood Pressure Raises Dementia Risk: Insights from 2.8 Million Adults Over 8 Years

Posted by By MedXY 04/15/2026
A landmark South Korean study of 2.8 million adults reveals that both elevated blood pressure and hypertension significantly increase dementia risk, particularly vascular dementia, with stronger effects observed in midlife adults and women. The findings validate the 2024 ESC blood pressure classification system.
Read More
Adenotonsillectomy Lowers Blood Pressure Percentiles in Children With Mild OSA — Greatest Benefit in Overweight Kids
Posted inCardiology news Pediatrics

Adenotonsillectomy Lowers Blood Pressure Percentiles in Children With Mild OSA — Greatest Benefit in Overweight Kids

Posted by By MedXY 11/20/2025
An exploratory analysis of the PATS randomized trial found early adenotonsillectomy reduced 12‑month systolic and diastolic BP percentiles versus watchful waiting in children with mild obstructive sleep‑disordered breathing, with larger DBP reductions among children with overweight/obesity.
Read More
Remote Ischemic Conditioning Lowers Systolic Blood Pressure in Uncontrolled Essential Hypertension: Results of the RICBP‑EH Randomised Trial
Posted inCardiology Internal Medicine news

Remote Ischemic Conditioning Lowers Systolic Blood Pressure in Uncontrolled Essential Hypertension: Results of the RICBP‑EH Randomised Trial

Posted by By MedXY 11/12/2025
A single‑centre randomized trial in China found that 7 days of remote ischemic conditioning (RIC) reduced average systolic BP by about 4.8 mm Hg versus sham in patients with essential hypertension (SBP ≥140 mm Hg), with good tolerability.
Read More
Optimizing Food Insecurity Interventions to Lower Blood Pressure: Insights from the Healthy Food First Trial
Posted inCardiology Family Medicine & Nutrition Specialties

Optimizing Food Insecurity Interventions to Lower Blood Pressure: Insights from the Healthy Food First Trial

Posted by By MedXY 10/21/2025
A factorial RCT in food-insecure adults with hypertension found that healthy food subsidies modestly reduced blood pressure compared with delivered food boxes, while lifestyle counseling and longer duration showed no added benefit.
Read More
Harnessing Flavan-3-ols for Cardiovascular Health: Impacts on Blood Pressure and Endothelial Function
Posted inCardiology Family Medicine & Nutrition news Public Health

Harnessing Flavan-3-ols for Cardiovascular Health: Impacts on Blood Pressure and Endothelial Function

Posted by By MedXY 10/12/2025
This systematic review and meta-analysis demonstrates that flavan-3-ol-rich foods significantly lower blood pressure and improve endothelial function, supporting their role in cardiovascular prevention, especially in individuals with elevated or hypertensive baseline blood pressure.
Read More
HEPA Air Purification Significantly Lowers Systolic Blood Pressure in Adults with Elevated BP Near Highways: Evidence from a Pragmatic Randomized Crossover Trial
Posted inCardiology Clinical Updates news Specialties

HEPA Air Purification Significantly Lowers Systolic Blood Pressure in Adults with Elevated BP Near Highways: Evidence from a Pragmatic Randomized Crossover Trial

Posted by By MedXY 09/19/2025
In-home HEPA air purifiers significantly reduce systolic blood pressure by 3.0 mm Hg in adults living near highways with elevated baseline BP, highlighting a practical intervention to mitigate cardiovascular risk from particulate pollution.
Read More
Intravenous Antihypertensives Post-Endovascular Thrombectomy: Implications for Functional Recovery in Acute Ischemic Stroke
Posted inClinical Updates Neurology news

Intravenous Antihypertensives Post-Endovascular Thrombectomy: Implications for Functional Recovery in Acute Ischemic Stroke

Posted by By MedXY 09/19/2025
Intravenous antihypertensive use within 24 hours after successful EVT in acute ischemic stroke associates with poorer functional outcomes and higher mortality, underscoring the need for cautious blood pressure management strategies post-thrombectomy.
Read More
Evaluating the Long-Term Effects of Cocoa Extract Supplementation on the Development of Hypertension: Insights from the COSMOS Trial
Posted inClinical Updates news

Evaluating the Long-Term Effects of Cocoa Extract Supplementation on the Development of Hypertension: Insights from the COSMOS Trial

Posted by By MedXY 09/19/2025
The large-scale COSMOS trial reveals that while long-term cocoa extract supplementation does not reduce overall incident hypertension in older adults, it significantly lowers risk among individuals with normal baseline systolic blood pressure.
Read More
Lower Your Blood Pressure by 8 mmHg in Just 10 Minutes a Day: The Power of Isometric Exercises
Posted inFamily Medicine & Nutrition news Specialties

Lower Your Blood Pressure by 8 mmHg in Just 10 Minutes a Day: The Power of Isometric Exercises

Posted by By MedXY 09/14/2025
Isometric exercises, a form of static muscle engagement, can lower blood pressure as effectively as some medications, offering a simple, drug-free way to protect your heart and vessels.
Read More
Mobile Text Messaging Enhances Glycemic and Blood Pressure Control in Adults with Uncontrolled Type 2 Diabetes
Posted inCardiology Clinical Updates Diabetes & Endocrinology Specialties

Mobile Text Messaging Enhances Glycemic and Blood Pressure Control in Adults with Uncontrolled Type 2 Diabetes

Posted by By MedXY 09/10/2025
A randomized trial in China shows that a 12-month mobile message-based intervention modestly improves HbA1c and systolic blood pressure in patients with uncontrolled type 2 diabetes, supporting mHealth strategies to manage cardiovascular risks.
Read More

Posts pagination

1 2 Next page

Take a game break

Explore a few games from MedXY.

Explore all games
  • Exercise as a Cognitive Buffer in Midlife Women: Insights into Domain-Specific Effects and Modality Differences
  • Empowering Safer Mobility Behaviors to Prevent Falls in Parkinson’s Disease: Insights from Clinicians and Researchers
  • Eating Difficulty as a Marker for Broader Functional Vulnerability and Cognitive Decline in Older Adults: Insights from Four Large Ageing Cohorts
  • Izalontamab Brengitecan Shows Promising Efficacy Over Platinum Chemotherapy in EGFR-Mutated NSCLC Post-Third-Generation EGFR TKI Progression
  • Longitudinal Executive Function Development in Very Preterm Children: Persistent Challenges into Adolescence
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top